According to the TMR report, the market for cancer biomarkers is expected to exceed US$31.4 billion by 2031

  • The cancer biomarkers market is expected to grow at a CAGR of 9.9% between 2022 and 2031
  • The global increase in cancer patient population is expected to contribute to expanding the market share of cancer biomarkers
  • Increase in R&D dedicated to developing effective cancer treatment solutions North America a leading market region

Wilmington, Del., September 20, 2022 /PRNewswire/ — The global cancer biomarkers market is forecast to exceed $31.4 billion by 2031, according to a research report by Transparency Market Research (TMR). Furthermore, the study highlights that the market is expected to develop at a CAGR of 9.9% during the forecast period of 2022 to 2031.

Players operating in the Cancer Biomarkers market are adopting different strategies such as joint ventures, collaborations, mergers and acquisitions in order to expand their regional presence and stay ahead of the competitors. Additionally, major players in the Cancer Biomarkers Market are focusing on new product launches to expand their product portfolio. Such factors are expected to play an important role in the overall development of the cancer biomarkers market in the near future, according to statistics analysts of a TMR study.

Get an exclusive PDF sample copy of Cancer Biomarkers Market Report –

Cancer Biomarkers Market: Key Findings

  • Cancer biomarkers are gaining increasing importance in the healthcare industry as they can aid in timely cancer diagnosis and the development of a personalized cancer treatment plan. In recent years there has been an increase in cases of various types of cancer worldwide, including ovarian cancer, small cell lung cancer and thyroid cancer. This factor leads to an increasing demand for HER2 biomarkers and CEA biomarkers for cancer detection, which in turn leads to a profitable prospect in the cancer biomarkers market.
  • TMR’s analysis of the demand for cancer biomarkers in the healthcare industry finds that the number of older people has been increasing worldwide. In addition, major healthcare organizations worldwide are increasing the adoption of technological advances to provide improved healthcare services to patients. These factors are fueling revenue growth in the cancer biomarkers market.
  • Protein biomarkers have been increasingly used in various cancer researches in recent years to precisely detect different types of cancer. Government agencies in several developed and developing countries around the world sponsor research projects focused on developing effective cancer treatment solutions. Therefore, emerging researchers in the field of cancer treatment are expected to drive the demand for protein biomarkers, which in turn is expected to lead the protein biomarkers segment to contribute the largest revenue share in the cancer biomarkers market during the forecast period.

Ask for references –

Cancer Biomarkers Market: Growth Booster

  • The global increase in cancer prevalence is expected to spur market growth, states the future market prospects of TMR for cancer biomarkers
  • The increasing adoption of advanced technologies for precise cancer diagnosis creates outstanding business opportunities in the cancer biomarker market

Make an Inquiry Before Buying –

Cancer Biomarkers Market: Regional Analysis

  • That North America The Cancer Biomarkers market is expected to expand during the forecast period owing to many factors such as: B. an increase in cancer cases in regional countries, including Canada and the US along with a surge in research and development focused on developing next-generation cancer biomarkers in the region
  • Players are expected to receive significant business opportunities Europe during the forecast period. The growth of Europe Market is attributed to rise in cancer population and increasing adoption of advanced technologies in cancer treatment in regional healthcare industry.

Cancer Biomarkers Market: Major Players

Some of the key players featured in the report are:

  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-LA Roche AG
  • Abbott Laboratories
  • Merck & Co, Inc.
  • PerkinElmer, Inc.
  • Bristol-Myers Squibb Company
  • Siemens AG
  • Qiagen NV
  • Novartis AG
  • Exact Sciences Corporation
  • Enlightenment
  • Bio-Rad Laboratories
  • Hologic, Inc.
  • Agilent Technologies Inc.
  • bioMerieux SA

Cancer Biomarkers Market Segmentation

  • Type
  • type of cancer
    • lung
    • Breast
    • leukemia
    • melanoma
    • colorectal
    • prostate
    • ovary
    • liver
    • Other
  • profiling technology
    • omic
    • imaging
    • immunoassay
    • bioinformatics
    • Other
  • application
    • diagnosis
    • R&D
    • forecast
    • Other

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • middle East & Africa

The modernization of healthcare, both in terms of infrastructure and services, has taken the healthcare industry to new heights. Stay up to date with the latest health research reports from Transparency Market Research:

Analytical Standards Market: The global analytical standards market is expected to reach more than $2.29 billion by the end of 2031 with a CAGR of 6.7% from 2022 to 2031.

Mouse Model Technologies Market: The global mouse model technologies market is expected to be reached $3.2 billion to 2031 with a CAGR of 7.4% from 2022 to 2031.

Soft Tissue Allografts Market: The global soft tissue allografts market is expected to reach more than $6.3 billion by the end of 2031 with a CAGR of 5.5% from 2022 to 2031.

Animal Genetics Market: The global animal genetics market is expected to reach more than $9.1 billion by the end of 2031 with a CAGR of 6.7% from 2022 to 2031.

Transplant Drug Monitoring Assays Market: The global transplant drug monitoring assays market is expected to exceed US$542 million by the end of 2031 with a CAGR of 11.0% from 2022 to 2031.

PRP and PRF in Cosmetics Market: The global PRP and PRF in Cosmetics Market is expected to be outperformed US$483 million to 2031 with a CAGR of 12.6% from 2022 to 2031.

Fetal Bovine Serum Market: The global Fetal Bovine Serum market is expected to surpass the value of $1.6 billion by the end of 2031 with a CAGR of 6.4% from 2021 to 2031.

Cell Culture Market: The global cell culture market is expected to reach the value of $27.6 billion by the end of 2031 with a CAGR of 9% from 2021 to 2031.

About transparency market research

Transparency Market Research, a global market research company, registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trend analysis provides forward-looking insights for thousands of decision makers. Our experienced team of analysts, researchers and consultants use proprietary data sources and various tools and techniques to collect and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so it always reflects the latest trends and information. With a broad research and analytical capacity, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive datasets and research material for business reports.

For more research insights on leading industries, visit our YouTube channel and click Subscribe to Future Update –


Rohit Bhisey
Transparency Market Research Inc.
1000 N West Street,
suite 1200, Wilmington, Delaware 19801 US
Tel: +1-518-618-1030
United States of America – Canada Toll Free: 866-552-3453
to blog:


SOURCE Transparency Market Research

Leave a Comment